The global neurointerventional devices market size was valued at USD 4.56 billion in 2018 and is anticipated to grow at a CAGR of 7.6% during the forecast period. Neurological devices can help diagnose, prevent, and treat a spread of neurological disorders and conditions like Alzheimer’s disease, Parkinson’s disease, major depression, epilepsy, medulla spinalis injury, and traumatic brain injury.